Angiostatin and endostatin: Endogenous inhibitors of tumor growth

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 181-190

  Sim, B K L ^a   MacDonald, N J ^a   Gubish, E R ^a  

^a ENTREMED INC   (United States)

Author keywords

Angiostatin; Antiangiogenesis; Endostatin

Indexed keywords

ANGIOSTATIN; ENDOSTATIN;

ANGIOGENESIS; ANIMAL CELL; CANCER INVASION; CELL PROLIFERATION; CELL VIABILITY; COMPETITIVE INHIBITION; COMPLEX FORMATION; ENDOTHELIUM CELL; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COLLAGEN; ENDOSTATINS; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; PLASMINOGEN; RECOMBINANT PROTEINS;

EID: 0034528855     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026551202548     Document Type: Review

References (68)

1. The suppression of tumor metastases by a primary tumor
2. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
3. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
4. Suppression of tumor growth with recombinant murine angiostatin
5. Angiostatin protein and other plasminogen fragments
6. Angiostatin and endostatin: Endothelial cell-specific endogenous inhibitors of angiogenesis and tumor growth
7. Angiostatin: A circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth
8. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
9. Angiostatin suppresses malignant glioma growth in vivo
10. Combined effects of angiostatin and ionizing radiation in antitumour therapy
11. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
12. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3
13. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD
14. Multiple forms of angiostatin induce apoptosis in endothelial cells
15. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells
16. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
17. Angiostatin upregulates E-selectin in proliferating endothelial cells
18. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
19. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin
20. Activation of immobilized plasminogen tissue activator. Multimolecular complex formation
21. Binding of plasminogen to extracellular matrix
22. Regulation of plasminogen activation by components of the extracellular matrix
23. Comparison of plasminogen binding and activation on extracellular matrices produced by vascular smooth muscle and endothelial cells
24. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator
25. Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: Evidence for a specific tissue-type plasminogen activator receptor on these cells
26. Angiostatin binds ATP synthase on the surface of human endothelial cells
27. Angiostatin's partners
28. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin
29. Administration of angiostatin: Bolus or continuously?
30. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
31. Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones
32. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin
33. The generation of endostatin is mediated by clastase
34. Secreted cathepsin L generates endostatin from collagen XVIII
35. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphohonate
36. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
37. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
38. Zinc liganddisrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile
39. Zinc-dependent dimers observed in crystals of human endostatin
40. Crystal structure of the angiogenesis inhibitor endostatin at 1.5. A resolution
41. Variable zinc coordination in endostatin
42. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin
43. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
44. Analysis of zinc binding sites in protein crystal structures
45. Endostatin induces endothelial cell apoptosis
46. Caspases: Intracellular signaling by proteolysis
47. Endostatin inhibits VEGF and bFGF induced MAPK activation in endothelial cells
48. Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding
49. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis
50. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing
51. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
52. Systemic gene delivery expands the repertoire of effective antiangiogenic agents
53. Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer
54. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostain gene
55. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
56. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model
57. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
58. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
59. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA
60. Cloning, expression, and in vitro activity of human endostatin
61. Angiostatin induces and sustains dormancy of human primary tumors in mice
62. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo
63. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy
64. Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3
65. Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth
66. Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model
67. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors
68. Angiostatin and angiostatin-related proteins